Cyramza, key to Lilly’s oncology hopes, comes through in colorectal cancer

Damian Garde Eli Lilly's Cyramza (ramucirumab) met its primary endpoint in a study on metastatic colorectal cancer, good news for a key cog in the drugmaker's plans to capitalize ...

Amgen’s Vectibix scores first-line approval in wild-KRAS colorectal cancer

John Carroll The FDA has OK'd the use of Amgen's Vectibix as a first-line treatment for wild-type KRAS metastatic colorectal cancer. The agency approved the frontline use of ...

MDxHealth Epigenetic Marker as Companion Diagnostic for Irinotecan based Therapy in Colorectal Cancer

barbara.lempert Data Presented at ASCO IRVINE, CA, and LIEGE, BELGIUM – 8:00 AM, June 3, 2013 – MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS